Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Current Leases: 2021-2024

Historic Current Leases for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Dec 2024 value amounting to $820,000.

  • Arcutis Biotherapeutics' Current Leases rose 11.38% to $842,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $842,000, marking a year-over-year increase of 11.38%. This contributed to the annual value of $820,000 for FY2024, which is 11.56% up from last year.
  • Arcutis Biotherapeutics' Current Leases amounted to $820,000 in FY2024, which was up 11.56% from $735,000 recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Current Leases ranged from a high of $820,000 in FY2024 and a low of $433,000 during FY2021.
  • Moreover, its 3-year median value for Current Leases was $735,000 (2023), whereas its average is $737,333.
  • Data for Arcutis Biotherapeutics' Current Leases shows a peak YoY skyrocketed of 51.73% (in 2022) over the last 5 years.
  • Arcutis Biotherapeutics' Current Leases (Yearly) stood at $433,000 in 2021, then surged by 51.73% to $657,000 in 2022, then increased by 11.87% to $735,000 in 2023, then rose by 11.56% to $820,000 in 2024.